EdgeMarketInstruments › SRZN

SRZN — Surrozen, Inc./DE

US Healthcare Pharma & biotech equity mkt cap 276.2M
23.99 +2.09% today
USD · as of 2026-08-21

Price · 2024-08-26 → 2026-08-21

499 daily closes shown
52w low 11.10 · high 34.13

Anonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2021-01-11.

Performance

1 day+2.09%
1 week+0.13%
1 month+13.37%
3 months-11.44%
6 months-9.78%
Year to date+11.32%
1 year+108.61%
3 years+162.19%
5 years-82.66%

Technicals

RSI 1463.7
vs 50-day avg+3.94%
vs 200-day avg+1.85%
Volatility 1y74.1%
Max drawdown 1y-43.74%
Avg volume 30d249.3K
Daily bars held1,410
History from2021-01-11

Measured signals that fired on SRZN

datesignal measured base rate
2026-07-24Cluster sale: three or more insiders
insider
-0.37% over 21 days · t = -3.38 · n = 21,542
statistically distinguishable from its control group
2026-07-17Equal lows taken out
structure
-0.64% over 21 days · t = -4.75 · n = 55,661
statistically distinguishable from its control group
2026-05-05Cluster sale: three or more insiders
insider
-0.37% over 21 days · t = -3.38 · n = 21,542
statistically distinguishable from its control group
2026-04-01Equal highs taken out
structure
-0.70% over 21 days · t = -8.28 · n = 68,636
statistically distinguishable from its control group

Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →

Insider transactions (Form 4)

dateinsiderwhatshares pricevalue
2026-07-22Yu Chen-Ming
10% owner
Open-market sale162.5K21.253.5M
2026-07-22TCG Crossover GP II, LLC
10% owner
Open-market sale162.5K21.253.5M
2026-07-22TCG Crossover GP II, LLC
10% owner
Open-market sale162.5K21.253.5M
2026-07-22TCG Crossover Fund II, L.P.
10% owner
Open-market sale162.5K21.253.5M
2026-07-22TCG Crossover Fund II, L.P.
10% owner
Open-market sale162.5K21.253.5M
2026-07-22TCG Crossover Fund III, L.P.
10% owner
Open-market sale162.5K21.253.5M
2026-07-22TCG Crossover Fund III, L.P.
10% owner
Open-market sale162.5K21.253.5M
2026-07-22TCG Crossover GP III, LLC
10% owner
Open-market sale162.5K21.253.5M
2026-07-22TCG Crossover GP III, LLC
10% owner
Open-market sale162.5K21.253.5M
2026-07-22Yu Chen-Ming
10% owner
Open-market sale162.5K21.253.5M

Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →

Largest institutional holders

managervalueshares
TCG Crossover Management, LLC42.9M1.5M
Kalehua Capital Management LLC22.4M770.4K
Boxer Capital Management, LLC22.3M766.3K
MILLENNIUM MANAGEMENT LLC21.3M731.1K
STEMPOINT CAPITAL LP19.2M721.6K
Venrock Adviser, LLC18.4M632.9K
Spruce Street Capital LP12.6M432.0K
BRAIDWELL LP11.5M396.1K
5AM Venture Management, LLC11.3M387.5K
Vestal Point Capital, LP9.9M338.6K

13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →

Latest SEC filings

formfiledperiod
SCHEDULE 13G/A2026-08-14on EDGAR ↗
SCHEDULE 13G/A2026-08-14on EDGAR ↗
SCHEDULE 13G2026-08-14on EDGAR ↗
SCHEDULE 13G/A2026-08-11on EDGAR ↗
25-NSE2026-08-07on EDGAR ↗
10-Q2026-08-062026-06-30on EDGAR ↗
8-K2026-08-062026-08-06on EDGAR ↗
SCHEDULE 13G/A2026-07-24on EDGAR ↗

Short selling

Avg short volume, 90d63.1% of tape
Days observed61

This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →

Ask the AI about SRZN

The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.

Open SRZN in the terminal → How the AI works

Everything on this page is live in the terminal.

Charts, filings, insider flow and the AI — open without an account.

Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →